ArticleCancer cell international2026

Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma.

Santhasiri Orrapin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.